Addressing Challenges of Economic Evaluation in Precision Medicine Using Dynamic Simulation Modeling. Read more about Addressing Challenges of Economic Evaluation in Precision Medicine Using Dynamic Simulation Modeling.
Quantifying Downstream Healthcare Utilization in Studies of Genomic Testing. Read more about Quantifying Downstream Healthcare Utilization in Studies of Genomic Testing.
Insights From a Temporal Assessment of Increases in US Private Payer Coverage of Tumor Sequencing From 2015 to 2019. Read more about Insights From a Temporal Assessment of Increases in US Private Payer Coverage of Tumor Sequencing From 2015 to 2019.
Novel Approaches to Value Assessment Within the Cost-Effectiveness Framework. Read more about Novel Approaches to Value Assessment Within the Cost-Effectiveness Framework.
R You Still Using Excel? The Advantages of Modern Software Tools for Health Technology Assessment. Read more about R You Still Using Excel? The Advantages of Modern Software Tools for Health Technology Assessment.
Assessing the Value of Next-Generation Sequencing Technologies: An Introduction. Read more about Assessing the Value of Next-Generation Sequencing Technologies: An Introduction.
Cost Analyses of Genomic Sequencing: Lessons Learned from the MedSeq Project. Read more about Cost Analyses of Genomic Sequencing: Lessons Learned from the MedSeq Project.
Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions. Read more about Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions.
From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing. Read more about From the Past to the Present: Insurer Coverage Frameworks for Next-Generation Tumor Sequencing.
Initial Development and Content Validation of a Health-Related Symptom Index for Persons either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions. Read more about Initial Development and Content Validation of a Health-Related Symptom Index for Persons either Treated or Monitored for Anal High-Grade Squamous Intraepithelial Lesions.
